These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 20619530)
1. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Kaag MG; O'Malley RL; O'Malley P; Godoy G; Chen M; Smaldone MC; Hrebinko RL; Raman JD; Bochner B; Dalbagni G; Stifelman MD; Taneja SS; Huang WC Eur Urol; 2010 Oct; 58(4):581-7. PubMed ID: 20619530 [TBL] [Abstract][Full Text] [Related]
2. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. Xylinas E; Rink M; Margulis V; Clozel T; Lee RK; Comploj E; Novara G; Raman JD; Lotan Y; Weizer A; Roupret M; Pycha A; Scherr DS; Seitz C; Ficarra V; Trinh QD; Karakiewicz PI; Montorsi F; Zerbib M; Shariat SF; BJU Int; 2013 Aug; 112(4):453-61. PubMed ID: 23464979 [TBL] [Abstract][Full Text] [Related]
3. Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma. Hashimoto T; Ohno Y; Nakashima J; Gondo T; Nakagami Y; Namiki K; Horiguchi Y; Yoshioka K; Ohori M; Tachibana M Jpn J Clin Oncol; 2015 Nov; 45(11):1064-8. PubMed ID: 26355160 [TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Lane BR; Smith AK; Larson BT; Gong MC; Campbell SC; Raghavan D; Dreicer R; Hansel DE; Stephenson AJ Cancer; 2010 Jun; 116(12):2967-73. PubMed ID: 20564402 [TBL] [Abstract][Full Text] [Related]
5. Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma. Silberstein JL; Power NE; Savage C; Tarin TV; Favaretto RL; Su D; Kaag MG; Herr HW; Dalbagni G J Urol; 2012 Feb; 187(2):429-34. PubMed ID: 22177163 [TBL] [Abstract][Full Text] [Related]
6. Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma. Kaag M; Trost L; Thompson RH; Favaretto R; Elliott V; Shariat SF; Maschino A; Vertosick E; Raman JD; Dalbagni G BJU Int; 2014 Nov; 114(5):674-9. PubMed ID: 24314050 [TBL] [Abstract][Full Text] [Related]
7. Comparing Changes in Renal Function After Radical Surgery for Upper Tract Urothelial Carcinoma and Renal Cell Carcinoma. Singla N; Hutchinson R; Menegaz C; Haddad AQ; Jiang L; Sagalowsky AI; Cadeddu JA; Lotan Y; Margulis V Urology; 2016 Oct; 96():44-53. PubMed ID: 27443467 [TBL] [Abstract][Full Text] [Related]
8. The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer. Song W; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG Urol Oncol; 2017 Mar; 35(3):114.e1-114.e7. PubMed ID: 27908680 [TBL] [Abstract][Full Text] [Related]
9. Perioperative outcomes of laparoscopic radical nephroureterectomy and regional lymphadenectomy in patients with upper urinary tract urothelial carcinoma after neoadjuvant chemotherapy. Rajput MZ; Kamat AM; Clavell-Hernandez J; Siefker-Radtke AO; Grossman HB; Dinney CP; Matin SF Urology; 2011 Jul; 78(1):61-7. PubMed ID: 21354598 [TBL] [Abstract][Full Text] [Related]
10. A systematic review and meta-analysis of oncological and renal function outcomes obtained after segmental ureterectomy versus radical nephroureterectomy for upper tract urothelial carcinoma. Fang D; Seisen T; Yang K; Liu P; Fan X; Singla N; Xiong G; Zhang L; Li X; Zhou L Eur J Surg Oncol; 2016 Nov; 42(11):1625-1635. PubMed ID: 27612412 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome. Yafi FA; Tanguay S; Rendon R; Jacobsen N; Fairey A; Izawa J; Kapoor A; Black P; Lacombe L; Chin J; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Kassouf W Urol Oncol; 2014 Jan; 32(1):31.e17-24. PubMed ID: 23428535 [TBL] [Abstract][Full Text] [Related]
12. Segmental ureterectomy vs. radical nephroureterectomy for ureteral carcinoma in patients with a preoperative glomerular filtration rate less than 90 ml/min/1.73 m Abrate A; Sessa F; Campi R; Preto M; Olivero A; Varca V; Benelli A; Sessa M; Sebastianelli A; Pavone C; Serretta V; Vella M; Brunocilla E; Serni S; Trombetta C; Terrone C; Gregori A; Lissiani A; Gontero P; Schiavina R; Gacci M; Simonato A Urol Oncol; 2020 Jun; 38(6):601.e11-601.e16. PubMed ID: 32273050 [TBL] [Abstract][Full Text] [Related]
13. Preoperative hydronephrosis is associated with less decline in renal function after radical nephroureterectomy for upper tract urothelial carcinoma. Singla N; Hutchinson R; Haddad A; Sagalowsky A; Lotan Y; Margulis V Can J Urol; 2016 Aug; 23(4):8334-41. PubMed ID: 27544555 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma. Liao RS; Gupta M; Schwen ZR; Patel HD; Kates M; Johnson MH; Hahn NM; McConkey D; Bivalacqua TJ; Pierorazio PM J Urol; 2018 Jul; 200(1):68-73. PubMed ID: 29307680 [TBL] [Abstract][Full Text] [Related]
15. Perioperative renal function change and oncological outcomes of radical nephroureterectomy in patients with upper tract urothelial carcinoma: A multicenter retrospective study. Muramoto K; Urabe F; Koike Y; Yamamoto S; Suzuki H; Miyajima K; Fukuokaya W; Iwatani K; Imai Y; Igarashi T; Mori K; Aikawa K; Kimura S; Tashiro K; Yamada Y; Sasaki T; Sato S; Yuen SKK; Shimomura T; Furuta A; Tsuzuki S; Miki J; Kimura T; Urol Oncol; 2024 Oct; 42(10):332.e21-332.e32. PubMed ID: 38729868 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma. Labbate CV; Hensley PJ; Miest TS; Qiao W; Adibi M; Shah AY; Chery L; Papadopoulos J; Siefker-Radtke AO; Gao J; Guo CC; Czerniak BA; Navai N; Kamat AM; Dinney CP; Campbell MT; Matin SF Urol Oncol; 2022 Oct; 40(10):454.e17-454.e23. PubMed ID: 35961847 [TBL] [Abstract][Full Text] [Related]
18. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy. Kitamura H; Igarashi M; Tanaka T; Shindo T; Masumori N; Tamakawa M; Kawaai Y; Tsukamoto T Jpn J Clin Oncol; 2012 Dec; 42(12):1192-6. PubMed ID: 23077244 [TBL] [Abstract][Full Text] [Related]
19. Risk factors associated with ineligibility of adjuvant cisplatin-based chemotherapy after nephroureterectomy. Shao IH; Lin YH; Hou CP; Juang HH; Chen CL; Chang PL; Tsui KH Drug Des Devel Ther; 2014; 8():1985-90. PubMed ID: 25364228 [TBL] [Abstract][Full Text] [Related]
20. Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract. Cho KS; Joung JY; Seo HK; Cho IC; Chung HS; Chung J; Lee KH Cancer Chemother Pharmacol; 2011 Apr; 67(4):769-74. PubMed ID: 20532510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]